DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Treatment of acute coronary syndromes in patients with type 2 diabetes mellitus with beta-adrenoblockers and angiotensin-converting enzyme inhibitors: cardiohemodynamic effects and impact for prognosis.

Author(s): Ivanova LA, Kanorskii SG, Rostovtseva ON, Halil Sufian B, Galenko-Yaroshevskii PA

Affiliation(s): Kuban State Medical Academy, Krasnodar.

Publication date & source: 2004-09, Bull Exp Biol Med., 138(3):301-4.

Publication type: Clinical Trial; Randomized Controlled Trial

Long-term oral treatment of patients with acute coronary syndromes and type 2 diabetes mellitus with beta-adrenoblockers and angiotensin-converting enzyme inhibitors is associated with positive, though ambiguous changes in the left-ventricular structure and function. These changes should be the reason for choosing optimal therapy ensuring better prognosis in this patient population.

Page last updated: 2007-10-18

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017